Carret Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
13,891
-48
-0.3% -$4.28K 0.12% 142
2025
Q4
$1.1M Sell
13,939
-1,162
-8% -$91.1K 0.1% 144
2025
Q3
$1.21M Sell
15,101
-247
-2% -$21.1K 0.12% 138
2025
Q2
$1.4M Buy
15,348
+103
+0.7% +$9.4K 0.15% 125
2025
Q1
$1.43M Sell
15,245
-73
-0.5% -$6.54K 0.16% 116
2024
Q4
$1.39M Sell
15,318
-1,002
-6% -$95.6K 0.15% 120
2024
Q3
$1.69M Buy
16,320
+27
+0.2% +$2.75K 0.18% 113
2024
Q2
$1.58M Buy
16,293
+27
+0.2% +$2.49K 0.18% 113
2024
Q1
$1.46M Buy
16,266
+52
+0.3% +$4.41K 0.17% 122
2023
Q4
$1.29M Sell
16,214
-124
-0.8% -$9.32K 0.16% 127
2023
Q3
$1.16M Sell
16,338
-330
-2% -$24.7K 0.16% 128
2023
Q2
$1.28M Sell
16,668
-23
-0.1% -$1.78K 0.17% 123
2023
Q1
$1.25M Buy
16,691
+78
+0.5% +$5.8K 0.17% 128
2022
Q4
$1.31M Sell
16,613
-31
-0.2% -$2.32K 0.18% 127
2022
Q3
$1.17M Buy
16,644
+207
+1% +$16.2K 0.17% 127
2022
Q2
$1.32M Sell
16,437
-437
-3% -$34.2K 0.18% 126
2022
Q1
$1.28M Buy
16,874
+691
+4% +$54.7K 0.15% 138
2021
Q4
$1.38M Sell
16,183
-648
-4% -$50.6K 0.15% 137
2021
Q3
$1.27M Sell
16,831
-64
-0.4% -$5.08K 0.15% 132
2021
Q2
$1.37M Sell
16,895
-416
-2% -$34K 0.16% 129
2021
Q1
$1.36M Sell
17,311
-348
-2% -$27.3K 0.17% 126
2020
Q4
$1.51M Sell
17,659
-149
-0.8% -$12.3K 0.2% 112
2020
Q3
$1.37M Sell
17,808
-1,650
-8% -$126K 0.21% 106
2020
Q2
$1.43M Sell
19,458
-400
-2% -$28.4K 0.23% 96
2020
Q1
$1.32M Sell
19,858
-800
-4% -$56.4K 0.25% 89
2019
Q4
$1.42M Hold
20,658
0.21% 109
2019
Q3
$1.52M Buy
20,658
+75
+0.4% +$5.44K 0.24% 98
2019
Q2
$1.48M Sell
20,583
-550
-3% -$39K 0.23% 96
2019
Q1
$1.45M Sell
21,133
-100
-0.5% -$6.46K 0.24% 94
2018
Q4
$1.26M Sell
21,233
-450
-2% -$28.2K 0.23% 95
2018
Q3
$1.45M Buy
21,683
+2,875
+15% +$191K 0.22% 104
2018
Q2
$1.22M Sell
18,808
-700
-4% -$45.8K 0.2% 111
2018
Q1
$1.4M Sell
19,508
-100
-0.5% -$7.2K 0.23% 103
2017
Q4
$1.48M Sell
19,608
-60
-0.3% -$4.38K 0.23% 99
2017
Q3
$1.43M Sell
19,668
-390
-2% -$28.1K 0.23% 102
2017
Q2
$1.49M Sell
20,058
-50
-0.2% -$3.71K 0.25% 95
2017
Q1
$1.47M Sell
20,108
-70
-0.3% -$4.9K 0.26% 92
2016
Q4
$1.32M Sell
20,178
-200
-1% -$13.7K 0.25% 94
2016
Q3
$1.51M Sell
20,378
-200
-1% -$14.8K 0.28% 90
2016
Q2
$1.51M Sell
20,578
-375
-2% -$26.7K 0.29% 86
2016
Q1
$1.48M Sell
20,953
-100
-0.5% -$6.65K 0.31% 84
2015
Q4
$1.4M Sell
21,053
-1,200
-5% -$79.8K 0.3% 86
2015
Q3
$1.41M Buy
22,253
+90
+0.4% +$5.88K 0.31% 88
2015
Q2
$1.45M Sell
22,163
-1,855
-8% -$126K 0.29% 96
2015
Q1
$1.67M Sell
24,018
-161
-0.7% -$11.1K 0.32% 87
2014
Q4
$1.67M Sell
24,179
-7
-0% -$473 0.32% 88
2014
Q3
$1.58M Sell
24,186
-466
-2% -$30.7K 0.31% 87
2014
Q2
$1.68M Buy
24,652
+1,904
+8% +$128K 0.32% 85
2014
Q1
$1.48M Sell
22,748
-521
-2% -$32.8K 0.29% 86
2013
Q4
$1.52M Buy
23,269
+75
+0.3% +$4.8K 0.31% 83
2013
Q3
$1.38M Buy
23,194
+2,559
+12% +$152K 0.31% 86
2013
Q2
$1.18M Buy
+20,635
New +$1.22M 0.25% 103

Other funds holding CL

Carret Asset Management's CL Position: Q1 2026 in Review

Carret Asset Management reduced its Colgate-Palmolive (CL) stake by 0.34% in Q1 2026, selling an estimated $4.28K and leaving 13,891 shares worth $1.18M. The position accounts for 0.12% of the portfolio, ranked #142.

Carret Asset Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.69M in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Carret Asset Management held 13,891 shares of Colgate-Palmolive worth $1.18M as of Q1 2026.
  • Carret Asset Management sold 48 Colgate-Palmolive shares in Q1 2026, an estimated $4.28K.
  • Colgate-Palmolive made up 0.12% of Carret Asset Management's portfolio in Q1 2026, its #142 holding.
  • Carret Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Carret Asset Management's Colgate-Palmolive position peaked at $1.69M in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.